
Christopher Heery, MD, medical oncologist, National Cancer Institute, discusses the potential underlying benefits of combination therapy in the treatment of patients with gastrointestinal (GI) cancers.

Your AI-Trained Oncology Knowledge Connection!


Published: July 9th 2016 | Updated: